Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

ConditionBreast Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorVanderbilt-Ingram Cancer Center

About this trial

RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer.

PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Breast lesion which is suspected to be cancer or a known diagnosis of breast cancer (any stage, at any point in the disease trajectory) who agrees to donate tissue/body fluids.

Individuals of all races and ethnic groups are eligible for this trial. There is no restriction regarding age, race, or ethnicity. The trial is open to the accrual of men and women.

Must sign informed consent for study of tumor specimens as part of a research project.

Must give permission for their tumor specimens to be obtained from outside institutions for molecular analyses.

Disqualifiers

None

Trial population

Patients with and without breast cancer.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

biologic sample preservation procedure
Other intervention
Tissue, urine and blood collection.

Treatment groups

4,000 Participants

are divided into 2 treatment groups

Group A: Patients with Breast Cancer1 intervention

Group B: Patients without breast cancer1 intervention

Trial outcomes

Primary outcomes

Creation of a tissue repository that contains DNA, RNA, or protein from tumor tissue or normal tissue, peripheral blood lymphocytes, and plasma that are linked to frozen and/or paraffin-embedded pathology specimens

Time frame

5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vanderbilt-Ingram Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov

Apply now